Trial Profile
Retrospective study of omalizumab in patients with chronic urticaria
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Aug 2015
At a glance
- Drugs Omalizumab (Primary)
- Indications Urticaria
- Focus Therapeutic Use
- 07 Aug 2015 New trial record